Results 131 to 140 of about 1,115 (165)
Some of the next articles are maybe not open access.

Changes in the proportions of an active pharmaceutical through cocrystals

Drug Development Research, 2021
AbstractIn this study, the modulation of amounts sulfathiazolium cations in different 2,6‐pyridinedicarboxylates is demonstrated. An uncommon monoionic sulfathiazolium zinc 2,6‐pyridinedicarboxylate (1:1 electrolyte) complex was characterized. Conventional sulfathiazolium zinc‐bis‐2,6‐pyridinedicarboxylate dianionic complexes (2:1 electrolyte) were ...
Abhay Pratap Singh   +2 more
openaire   +2 more sources

PHARMACEUTICAL COCRYSTALS

2017
The aim of this project is to improve cocrystal screening and solubility prediction methods.
openaire   +1 more source

Multicomponent pharmaceutical cocrystals: furosemide and pentoxifylline

Acta Crystallographica Section C Crystal Structure Communications, 2012
The combination of the active pharmaceutical ingredients furosemide [4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid] and pentoxifylline [3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione] produces a 1:1 cocrystal, C12H11ClN2O5S·C13H18N4O3, (I), a 1:1 cocrystal hydrate, C12H11ClN2O5S·C13H18N4O3·H2O, (II), and a 1:1 cocrystal ...
Dmitrijs, Stepanovs, Anatoly, Mishnev
openaire   +2 more sources

Pharmaceutical Cocrystals of Famotidine: Structural and Biopharmaceutical Evaluation

Journal of Pharmaceutical Sciences, 2022
Famotidine (FMT) an anti-ulcer drug, recently being repurposed in COVID-19 treatment, suffers from poor aqueous solubility and restricted bioavailability (
Akshita Jindal   +6 more
openaire   +2 more sources

Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals

International Journal of Pharmaceutics, 2012
Cocrystals (CCs) used in the pharmaceutical industry are defined as complex crystals formed by reaction between an API and a cocrystal former (CCF); unlike salts, CCs do not show proton transfer. Recently, pharmaceutical CCs have been used to improve the drug-likeness of APIs, such as solubility and stability.
Katsuhiko, Yamamoto   +2 more
openaire   +2 more sources

ChemInform Abstract: Pharmaceutical Cocrystals

ChemInform, 2011
AbstractReview: 98 refs.
Ning Qiao   +5 more
openaire   +1 more source

Solubility Advantage of Pharmaceutical Cocrystals

Crystal Growth & Design, 2009
Pharmaceutical cocrystals can improve solubility, dissolution, and bioavailability of poorly water soluble drugs. However, true cocrystal solubility is not readily measured for highly soluble cocrystals because they can transform to the most stable drug form in solution.
David J. Good, Naír Rodríguez-Hornedo
openaire   +1 more source

Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics

Expert Opinion on Drug Metabolism & Toxicology, 2014
Pharmaceutical cocrystallization has emerged in the past decade as a new strategy to enhance the clinical performance of orally administered drugs. A pharmaceutical cocrystal is a multi-component crystalline material in which the active pharmaceutical ingredient is in a stoichiometric ratio with a second compound that is generally a solid under ambient
Ning, Shan   +3 more
openaire   +2 more sources

Pharmaceutical cocrystals: along the path to improved medicines

Chemical Communications, 2016
Cocrystals, a long known but understudied class of crystalline solids, have attracted interest from crystal engineers and pharmaceutical scientists in the past decade and are now an integral part of the preformulation stage of drug development.
Naga K, Duggirala   +3 more
openaire   +2 more sources

Cocrystal Systems of Pharmaceutical Interest: 2009

2011
As scientists become more aware of a substantial expansion in the scope of solid-state structural variations that can be obtained through the cocrystallization of several molecules in a single lattice structure, studies of the mixed molecular crystal systems known as cocrystals have mushroomed. Along these lines, workers have researched the assembly of
openaire   +2 more sources

Home - About - Disclaimer - Privacy